SILICON LABORATORIES INC. quarterly report, Q2 FY2026

Business Context and Reporting Period

Company: Silicon Laboratories Inc. (SLAB)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended July 4, 2026
Business Overview: A fabless semiconductor company providing mixed-signal analog-intensive products for the Internet of Things (IoT), including industrial, commercial, home, and life applications. The company relies on third-party foundries, primarily in Asia, for manufacturing.

Key Financial Metrics

Metric (in thousands) 3 Months Ended
July 4, 2026
6 Months Ended
July 4, 2026
3 Months Ended
July 5, 2025
6 Months Ended
July 5, 2025
Revenues $228,189 $441,689 $192,845 $370,559
Gross Profit $140,674 $267,672 $108,109 $205,886
Gross Margin 61.6% 60.6% 56.1% 55.6%
Operating Loss $(10,666) $(27,748) $(22,867) $(54,947)
Net Loss $(10,592) $(26,489) $(21,817) $(52,287)
Loss Per Share (Diluted) $(0.32) $(0.80) $(0.67) $(1.61)
Cash & Equivalents $362,191 Short-term investments: $35,051 (July 4, 2026)
Total Liquidity: $397.2 million
Inventory $123,340
Days Sales Outstanding (DSO) 31 days Days Inventory (DOI): 127 days
Debt: $0 outstanding on $400M facility
Operating Cash Flow (6mo) $(9,578)

Material Changes vs. Prior Period

  • Revenue Growth: Revenues increased 18.3% ($35.3M) for the quarter and 19.2% ($71.1M) for the six months compared to the prior year periods. Growth was driven by higher unit volumes in both Industrial & Commercial (+23.0% QoQ) and Home & Life (+12.2% QoQ) segments.
  • Margin Expansion: Gross margin improved to 61.6% from 56.1% year-over-year due to revenue growth outpacing indirect and overhead expenses.
  • Expense Increases: Operating expenses rose $20.4M in the quarter, primarily due to higher personnel costs and $9.6M in merger-related costs. Selling, General, and Administrative (SG&A) expenses increased 30.3% year-over-year, largely driven by $6.3M in merger costs and higher personnel expenses.
  • Loss Reduction: Net loss narrowed significantly to $10.6M from $21.8M in the prior year quarter, reflecting improved operational efficiency and revenue growth.
  • Inventory Build: Inventory increased to $123.3M (127 days of inventory) from $95.6M at the start of the fiscal year to mitigate supply chain disruptions and meet forecasted demand.

Guidance, Outlook, and Risks

  • Proposed Merger: The company is in the process of merging with Texas Instruments Incorporated (TI). The transaction, approved by stockholders on April 30, 2026, involves an all-cash offer of $231.00 per share. Closing is expected in the first half of 2027, subject to regulatory approvals. Merger-related costs incurred were $9.6M for the quarter and $20.8M for the six months.
  • Liquidity: The company maintains strong liquidity with $397.2M in cash, cash equivalents, and short-term investments. It has a $400M revolving credit facility with no outstanding borrowings and is in compliance with all covenants.
  • Macroeconomic Risks: Management cites inflation, high interest rates, geopolitical tensions (including conflicts in Ukraine and Iran), and potential trade tariffs as key uncertainties that could impact demand and costs.
  • Supply Chain: As a fabless company, SLAB relies on third-party foundries (primarily TSMC and SMIC) and assembly/test subcontractors in Asia. Risks include capacity constraints, geopolitical instability in the Pacific Rim, and shortages of memory components.
  • Outlook: While specific forward-looking revenue guidance is not provided in this text, management notes that the semiconductor industry is cyclical and subject to significant fluctuations. The company expects to continue incurring significant merger-related costs prior to closing.

Investor Verification Checklist

  • Merger Status: Verify the timeline for regulatory approvals and the likelihood of closing the Texas Instruments merger in H1 2027.
  • Inventory Levels: Assess the risk of inventory obsolescence given the 127-day inventory level and the cyclical nature of the semiconductor industry.
  • Merger Costs: Monitor the trajectory of merger-related expenses, which are currently impacting operating margins and net income.
  • Geographic Concentration: Review exposure to China (31% of revenue by shipped-to location) and the impact of potential trade restrictions or geopolitical tensions.
  • Valuation Allowance: Confirm the status of the valuation allowance on deferred tax assets in the U.S. and Singapore, which limits the recognition of tax benefits from operating losses.